Home/Filings/4/0000899243-20-005595
4//SEC Filing

Orford Keith 4

Accession 0000899243-20-005595

CIK 0001496671other

Filed

Feb 23, 7:00 PM ET

Accepted

Feb 24, 4:05 PM ET

Size

4.7 KB

Accession

0000899243-20-005595

Insider Transaction Report

Form 4
Period: 2020-02-20
Orford Keith
SR. VP, CLINICAL DEVELOPMENT
Transactions
  • Sale

    Common Stock

    2020-02-20$8.00/sh3,021$24,1688,541 total
Footnotes (1)
  • [F1]Reported transaction occurred pursuant to a Rule10b5-1 Trading Plan.

Issuer

Calithera Biosciences, Inc.

CIK 0001496671

Entity typeother

Related Parties

1
  • filerCIK 0001670740

Filing Metadata

Form type
4
Filed
Feb 23, 7:00 PM ET
Accepted
Feb 24, 4:05 PM ET
Size
4.7 KB